Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 281,966
  • Shares Outstanding, K 28,890
  • Annual Sales, $ 74,550 K
  • Annual Income, $ 42,480 K
  • 60-Month Beta -3.60
  • Price/Sales 3.81
  • Price/Cash Flow 7.12
  • Price/Book 3.53
Trade CODX with:

Options Overview Details

View History
  • Implied Volatility 77.68%
  • Historical Volatility 38.69%
  • IV Percentile 11%
  • IV Rank 12.41%
  • IV High 188.05% on 09/29/20
  • IV Low 62.04% on 06/25/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 619
  • Volume Avg (30-Day) 842
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 9,012
  • Open Int (30-Day) 11,056

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.21
  • Number of Estimates 1
  • High Estimate 0.21
  • Low Estimate 0.21
  • Prior Year 0.53
  • Growth Rate Est. (year over year) -60.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.45 +3.28%
on 09/20/21
11.44 -14.69%
on 08/25/21
-1.06 (-9.80%)
since 08/24/21
3-Month
7.35 +32.80%
on 07/15/21
11.82 -17.43%
on 08/17/21
+1.06 (+12.18%)
since 06/24/21
52-Week
7.01 +39.23%
on 05/13/21
20.69 -52.82%
on 02/09/21
-4.02 (-29.17%)
since 09/24/20

Most Recent Stories

More News
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion

/PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that...

CODX : 9.76 (-0.81%)
Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today...

CODX : 9.76 (-0.81%)
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico

/PRNewswire/ -- Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Influenza A/Influenza...

CODX : 9.76 (-0.81%)
Sidoti Fall Virtual Small Cap Investor Conference

FLWS : 33.94 (-1.02%)
ATEN : 14.62 (+0.83%)
ACCO : 8.85 (-1.78%)
ALG : 144.67 (-1.50%)
AIN : 78.35 (-0.27%)
ALCO : 34.48 (-0.69%)
ABML : 1.6200 (+5.19%)
AMWD : 66.25 (-1.31%)
APOG : 37.98 (-0.52%)
AHT : 15.76 (+1.68%)
AINC : 13.77 (-2.07%)
AVA : 39.19 (+0.33%)
AX : 46.65 (+0.09%)
BBSI : 78.48 (+2.43%)
BKEP : 3.12 (-0.32%)
BRC : 50.88 (+0.04%)
BHR : 5.11 (+0.79%)
CASY : 189.28 (+0.46%)
CRAI : 97.10 (-0.68%)
CPK : 122.20 (-0.31%)
CODX : 9.76 (-0.81%)
FIX : 72.17 (-0.44%)
CNXN : 45.18 (-0.13%)
CRD.B : 9.09 (+2.09%)
CSGS : 48.05 (+1.29%)
CTS : 31.58 (+0.35%)
DPM.TO : 8.07 (+2.80%)
WIRE : 97.29 (+3.28%)
NPO : 85.58 (-0.22%)
PLUS : 104.07 (-0.35%)
FARM : 8.83 (-1.67%)
FORR : 50.27 (+1.13%)
FELE : 82.28 (-0.18%)
GENTF : 48.8400 (-2.82%)
GBL : 25.39 (-2.08%)
GATX : 88.27 (+0.83%)
GNE : 6.57 (+0.77%)
ROCK : 66.50 (-2.15%)
GLT : 14.69 (unch)
GIC : 38.24 (+0.68%)
GHM : 12.71 (+2.09%)
GFF : 23.65 (-0.08%)
HVT : 35.83 (-0.19%)
HAYN : 36.45 (-1.17%)
HRTG : 7.08 (+1.00%)
HI : 41.32 (-1.27%)
HOFT : 27.14 (+2.49%)
HURN : 51.55 (-0.29%)
HY : 53.05 (-0.36%)
ICFI : 88.64 (+0.24%)
Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that , CEO, , CFO,...

CODX : 9.76 (-0.81%)
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests

/PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today...

CODX : 9.76 (-0.81%)
Demand Continues to Grow for Crucial Medical Supplies

/PRNewswire/ -- The emergence of the pandemic has helped accelerate the growth of demand for diagnostic supplies such as ventilators, N95 masks, and PPE kits, which in turn is fueling the medical supplies...

OPTI : 0.0307 (+0.66%)
PAVM : 9.20 (-2.02%)
MREO : 2.41 (-2.82%)
PDSB : 16.56 (-3.04%)
CODX : 9.76 (-0.81%)
Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference

/PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today...

CODX : 9.76 (-0.81%)
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19...

CODX : 9.76 (-0.81%)
Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C.

/PRNewswire/ --Co-Diagnostics, Inc.(Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today...

CODX : 9.76 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 10.17
2nd Resistance Point 10.01
1st Resistance Point 9.88
Last Price 9.76
1st Support Level 9.59
2nd Support Level 9.43
3rd Support Level 9.30

See More

52-Week High 20.69
Fibonacci 61.8% 15.46
Fibonacci 50% 13.85
Fibonacci 38.2% 12.23
Last Price 9.76
52-Week Low 7.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar